ROIV
Roivant Sciences Ltd.
$36.31
+0.92 (+2.60%)
At close · Jul 7
Market Cap
$26.12B
Shares
719,270,385
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-20 | — | |
| 10-K | 2026-05-20 | 2026-03-31 | |
| 8-K | 2026-04-02 | — | |
| 8-K/A | 2026-03-23 | 2026-03-03 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-03-03 | — | |
| 10-Q | 2026-02-06 | 2025-12-31 | |
| 8-K | 2026-02-06 | — | |
| 8-K | 2025-12-11 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| Investor Event Transcript | 2025-09-30 | — | |
| Investor Event Transcript | 2025-09-30 | — | |
| Investor Event Transcript | 2025-09-30 | — | |
| 8-K | 2025-09-17 | — | |
| 8-K | 2025-09-11 | 2025-09-10 | |
| 8-K | 2025-09-03 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| DEF 14A | 2025-07-29 | 2025-09-10 | |
| 8-K | 2025-06-25 | 2025-06-24 | |
| 8-K | 2025-05-29 | — | |
| 10-K | 2025-05-29 | 2025-03-31 | |
| 8-K | 2025-04-21 | — | |
| 8-K | 2025-03-20 | 2025-03-16 | |
| 8-K | 2025-03-19 | — | |
| 8-K | 2025-02-21 | 2025-02-19 | |
| 8-K | 2025-02-10 | — | |
| 10-Q | 2025-02-10 | 2024-12-31 | |
| 8-K | 2024-12-03 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-28 | — | |
| 8-K | 2024-09-23 | 2024-09-17 | |
| 8-K | 2024-09-18 | — | |
| 8-K | 2024-09-16 | 2024-09-10 | |
| 8-K | 2024-09-10 | — | |
| 8-K | 2024-09-09 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| DEF 14A | 2024-07-26 | 2024-09-10 | |
| 8-K | 2024-05-30 | — | |
| 10-K | 2024-05-30 | 2024-03-31 | |
| 8-K | 2024-05-30 | 2024-05-24 | |
| 8-K | 2024-04-02 | — | |
| 10-Q | 2024-02-13 | 2023-12-31 | |
| 8-K | 2024-02-13 | — | |
| 8-K/A | 2023-12-20 | 2023-12-14 | |
| 8-K | 2023-12-20 | — | |
| 8-K | 2023-12-14 | — |
Showing 1–50 of 103 filings